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Summary It has been hypothesized that a disturbance of glutathione (GSH) metabolism might be a common factor in 
many psychiatric disorders. The aim of the present study was to test this hypothesis in transient acute psychotic 
patients with distorted perceptions. Since the metabolism of GSH is related to that of thromboxane B2 (TXB2), 
prostaglandin E (PGE) and some amino acids, we determined these substances in the plasma of 15 patients and 17 
normal controls. Plasma concentrations of TXB2 were significantly higher and concentrations of serine and tryptophan 
were significantly lower in patients than in controls. Large variation was observed in plasma PGE levels in patients, 
although mean values did not differ significantly from controls. These results are consistent with the hypothesis that 
the metabolism of GSH is impaired in transient psychotic states. 
INTRODUCTION 
Eicosanoids are one of the many substances that have 
been implied in psychosis and schizophrenia. 1 An early 
hypothesis that schizophrenia may be a prostaglandin 
(PG) deficiency disease was based on the following facts: 
(a) many antipsychotics stimulate prolactin secretion, 
which in turn stimulates PG synthesis, (b) schizophrenia 
excludes pain, inflammation and rheumatoid arthritis 
and concomitant PG levels are low and (c) schizophrenia- 
like syndromes can be induced by PG antagonists. 2 
However, the results of PG supplementation studies are 
contradictory I and plasma levels of PGE2 in schizophrenic 
patients were found to be both decreased 3 and increased. 4 
On the other hand, increased plasma phospholipase -42 
(PLA2) activity has been found in schizophrenic patients 
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and antipsychotic drugs like haloperidol, chlorpromazine 
and trifluoperazine, reduced the activity of PLA2. 5 Since 
PLA2 is a key enzyme in the formation of arachidonic acid 
from phospholipids, up-regulation of prostaglandin syn- 
thesis in schizophrenia is more likely and the clinical 
effect of antipsychotic drugs is not due to elevation of 
prolactin but rather a result of PLA~ inhibition. 
A special type of psychosis - the transient acute poly- 
morphic psychosis with or without symptoms of schizo- 
phrenia according to ICD-IO criteria 6- has been studied 
by Bruinvels et al7 and Fekkes et al. 8 This psychosis is 
characterized by psychosensory s mptoms of the type 
seen after LSD ingestion. From the available biochemical 
data it was hypothesized that the disturbed metabolism 
of serine (Set) in these patients leads to an increased for- 
mation of NS,Nl°-methylene-tetrahydrofolate. The latter 
substance can dissociate into among others formalde- 
hyde, which in turn may react with indolamines yielding 
B-carbolines, of which some are hallucinogenic. 7 
Studying the biochemistry of schizophrenic and the 
above mentioned psychotic patients, it became apparent 
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that there is one factor in common with all described 
biochemical alterations, viz the metabolism of gluta- 
thione (GSH). Evidence that alterations in GSH metabo- 
lism may be involved in psychiatric manifestations comes 
from the observation that schizophrenic women exhibit 
abnormal activities of GSH peroxidase 9 and that schizo- 
phrenics may benefit from GSH infusion} ° The hypoth- 
esized excess in formaldehyde l vels in the transient 
psychotic patients may be explained by a combination of 
an increased Ser metabolism and a decreased formalde- 
hyde dehydrogenase activity, due to a low level of its 
co-enzyme GSH. 
In the present study, we examined the alterations in 
GSH in an indirect way in transient psychotic patients 
with psychedelic symptoms and normal controls by 
measuring the plasma levels of some amino acids related 
to GSH metabolism and the levels of PGE and throm- 
boxane B2 (TXBJ. The eicosanoids were measured, be- 
cause the formation of PGE is dependent on the co-factor 
GSH ~1 and TXB2 levels have been found to be inversely 
correlated with GSH levels. 12 
SUBJECTS AND METHODS 
Subjects 
15 transient acute psychotic patients all with distorted 
sensory perceptions (8female, 7 male; age = 34 + 12 years, 
mean _+ SD), who were drug-free for at least 3 weeks, and 
17 normal controls (10 female, 7 male; age = 32 + 6 years, 
mean _+ SD), were included in the study. All patients were 
diagnosed according to ICD-10 criteria: ~9 patients suf- 
fered from polymorphic episodic psychosis (F 23.0 and 
23.1), 4 from organic delusional schizophrenia-like dis- 
order (F 06.2), 1 from mania with psychotic symptoms (F 
30.2) and 1 from substance abuse disorder (cannabinoids; 
F 12.53). At the moment of blood sampling the mental 
states of the patients were rated as not psychotic (n = 3), 
slightly disturbed, e.g. depersonalization (n = 4) and full- 
blown psychotic (n = 8). From one polymorphic psychotic 
patient, in whom psychedelic symptoms could be evoked 
with Ser, a sample was taken during two different periods 
of full-blown psychosis. For statistical reasons biochemi- 
cal determinations of these two samples were averaged. 
The study was approved by the Medical Ethical Com- 
mittee of the university. 
Procedures 
Venous blood samples were drawn between 09:00 and 
10:00, using 10 ml siliconized monoject tubes containing 
0.15% EDTA. Blood was centrifuged for 20 min at 20°C 
and 2650 x gmax and the plasma was stored at -30°C until 
analysis. 
Laboratory methods 
Amino acid analysis was performed as described previ- 
ously2 ~ We also determined the so-called TSM-ratio, 
which is defined as the ratio of 100 times the taurine 
(Tan) concentrations in plasma and the product of the 
plasma concentrations of Ser and methionine (Met).8 
Determination of the eicosanoids PGE and TXBz was 
performed by a simple and routine radioimmunoassay? 4 
Statistics 
Group differences were tested with a multivariate analysis 
of variance (MANOVA), followed by univariate analysis 
of variance (ANOVA) for each individual variable. Homo- 
geneity of variance was tested using Box's M-test The 
values given are means _+ SD; the level of significance was 
set at 5% (two-tailed). 
RESULTS 
The plasma concentrations of the measured amino acids 
and eicosanoids are shown in Table 1. Ser, Met and PGE 
were not normally distributed. Therefore, a logarithmic 
transformation was performed on these variables for 
statistical analysis. Two cases were omitted due to the 
occurrence of extreme values. One case was the patient 
suffering from mania with psychotic symtoms, who 
exhibited an extremely high plasma level of TXB2, viz 
2432 pg/ml (normal value in this study: 173 pg/ml). Al- 
though the numerical value was not reliable, this patient 
was no exception in the way patients deviated from con- 
trols. The other case was a patient suffering from poly- 
morphic psychosis, who showed a very low (18 pg/ml) 
plasma level of PGE (normal value in this study: 781 pg/ 
ml). The multivariate test yielded statistically significant 
results (F= 4.61; df = Z22; P= 0.003). Univariate F-tests 
showed that this effect could be attributed to differences 
in Ser, tryptophan (Trp), TXB2 and the TSM-ratio (Table 1). 
The plasma Ser and Trp levels of the psychotic patients 
Table 1 Concentrations of amino acids, TXB2 and PGE, and TSM- 
ratios in plasma of patients and normal controls. 
Controls Patients 
Variable (n = 17) (n = 13) P value 
Tau (#mol/I) 52 + 12 51 + 11 NS 
Ser (~,mol/I) 136 _+ 35 107 _+ 21 0.012 
Met (#mol/I) 26 _+ 7 22 + 3 NS 
Trp (#mol/I) 50 + 12 35 + 12 0.003 
TSM-ratio 1.69 + 0.71 2.30 _+ 0.62 0.020 
TXB2 (pg/ml) 173 _+ 106 382 _+ 122 < 0.001 
PGE (pg/ml) 781 + 185 862 _+ 458 NS 
All results are expressed as means _+ SD. n = number of 
individuals. NS = not significantly different from controls. 
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were significantly lower than those of normal controls 
(ANOVA, P = 0.012 and 0.003, respectively; Table 1). Met 
levels were also lower, but these differences were not sig- 
nificant. Mean plasma Tan levels did not differ between 
the two groups. The TSM-ratio appeared to be higher in 
the patients than in the control group (P = 0.020). Of the 
eicosanoids, the TXB2 levels in plasma of the patients 
were significantly higher than those of the controls 
(P< 0.001), whereas mean PGE levels did not differ be- 
tween these groups. It has to be noted that the SD of the 
PGE levels in plasma of the patients was very high. Even 
in the same patient, variation in PGE levels were high. For 
instance, in the plasma of the patient of whom 2 blood 
samples were taken, the PGE levels were 0 and 1114 pg/ 
ml, respectively. 
Further subdivision of patients and controls regarding 
age, plasma levels of Tau, Ser, Met and Trp, the TSM-ratio, 
and the plasma levels of TXB2 and PGE as measured vari- 
ables against groupings of the subjects in patients and 
controls with subdivisions in male/female, mental state of 
the patient and other above mentioned characteristics, 
did not reveal any further significant differences. 
DISCUSSION 
The aim of this study was to find more solid proof for 
the hypothesis that in a group of psychiatric patients, 
suffering from transient acute psychotic disorders with 
psychosensory s mptoms, GSH metabolism is altered. In- 
direct measurement of GSH by way of determination of
the plasma levels of the eicosanoids TXB2 and PGE was 
chosen, because we lack the technique to measure GSH. 
The two parameters TXB2 and PGE were selected, be- 
cause TXB2 concentrations have been found to be in- 
versely correlated with GSH concentrations 12,15,~6 and PGE 
uses GSH as a co-substrate for its formation. 11,16 
As explained above, the patients suffering from poly- 
morphic psychosis are expected to have increased formal- 
dehyde levels, zWhether this is due to a deficiency in GSH 
synthesis or that excess formaldehyde l ads to a reduc- 
tion in GSH concentration is not clear. In any case, our 
finding of a two-fold increase in TXB2 in all patients 
versus controls (Table 1) is in line with a decreased GSH 
availability. Although the mean plasma PGE levels did not 
differ between the two groups, its variation in the patient 
group was 2.5 times higher (SD = 494 pg/ml) than in the 
normal controls (SD = 185pg/ml). This indicates that 
GSH concentrations in episodic psychotic patients may 
fluctuate rapidly. The patient observed uring different 
periods of psychosis howed during both periods elevated 
plasma TXB2 levels (708 and 610 pg/ml TXB2, respectively), 
whereas the plasma PGE concentration was at one time 
elevated and at the other reduced (1114 and 0 pg/ml PGE, 
respectively). Probably, the determination of TXB2 tells us 
more about the direction of change in GSH levels than 
the measurement of PGE, because the effects of GSH on 
PGE are somewhat difficult to interpret. For instance, it 
has been found that formation of PGE2 is inhibited in the 
presence of 1 mM GSH, whereas 0.1 rnM GSH stimulated 
its synthesisY Therefore, TXB2 is regarded as the most 
important parameter. 
A significant decrease in plasma Trp levels was found 
in the studied psychotic patients. This may be explained 
by an increase in the synthesis of NADPH - Trp is a pre- 
cursor of NADPH - in order to keep sufficient GSH in a 
reduced state. It is conceivable that not only the absolute 
level of GSH is important, but also the ratio between 
reduced and oxidized GSH. 
The observed increased TSM-ratio in the psychotic 
patients compared to normal controls is mainly due to a 
decrease in plasma Ser level, because the levels of Tau and 
Met were not changed significantly. The plasma Ser levels 
of the 9 patients suffering from polymorphic psychosis 
(ICD-10 categories F 23.0 and 23.1) were slightly lower 
than those of the whole patient group (98 + 21 and 106 + 
20 gmol/1, respectively), while the TXB2 levels were com- 
parable (399 + 145 and 373 + 122 pg/ml, respectively). 
In conclusion, the plasma TXB2 levels of psychotic pa- 
tients with distorted perceptions were found to be signifi- 
cantly higher than those of normal controls, while the 
concentrations ofthe amino acids Trp and Ser were lower. 
Moreover, the variation in plasma PGE levels of the psy- 
chotic patients was more than 2-fold higher than in the 
control group. All differences found point to a distur- 
bance in the metabolism of GSH in transient acute psy- 
chosis and suggest that GSH is involved in the etiology of 
the psychosensory s mptoms. Whether this must be in- 
terpreted in terms of active oxygen species involvement 
or excess formaldehyde formation cannot be answered 
yet. 
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